Jim Dobbin – 2014 Parliamentary Question to the Department for Environment, Food and Rural Affairs
The below Parliamentary question was asked by Jim Dobbin on 2014-06-04.
To ask the Secretary of State for Environment, Food and Rural Affairs, pursuant to the Answer of 6 May 2014, Official Report, column 41W, on drinking water, whether his Department has conducted a study of levels of psychotropic drugs in UK rivers and seawater.
Dan Rogerson
Currently no psychotropic drugs have been identified as Priority Hazardous Substances, Priority Substances or UK Specific Pollutants under the Water Framework Directive. As such no routine monitoring is carried out for these substances in England.
However, previous research by the Environment Agency on pharmaceuticals in surface waters included environmental monitoring for the psychotropic drug fluoxetine (an anti-depressant). In 2005, monitoring was undertaken in rivers downstream of a number of sewage works across England and Wales. Thirty-nine samples were taken with fluoxetine occurring in 85% of samples with a maximum concentration of 0.044 microgrammes/litre (µg/l), and norfluoxetine in 51% of samples with a maximum concentration of 0.083 µg/l.
During 2011, a programme of monitoring for pesticides was undertaken in six catchments. The psychotropic drugs carbamazepine and gabapentin were detected in all six catchments with maximum levels of 0.7 µg/l and 1.2 µg/l respectively.
The report published by the Drinking Water Inspectorate evaluated the risk from psychotropic drugs in river water used for abstraction for drinking water supplies.
